Related Experiment Video
Updated: Jun 23, 2026

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
[Quantitative estimate of the risk of blood donation contamination by infectious agents]
J Pillonel1, C Brouard, S Laperche
1Institut de Veille Sanitaire, 94415 Saint-Maurice cedex, France. j.pillonel@invs.sante.fr
Abstract:
The occurrence of asymptomatic penetration of certain infectious agents in blood presents a risk of transmission of one of these agents during blood transfusion. Although well controlled for some infectious agents (HIV, HTLV, HCV, HBV), this risk is nevertheless neither documented nor quantified for other pathogens that are responsible for serologically unscreened or undetectable infections at the time of blood donation. This risk is generally low in endemic situations, although it increases for particular time periods and locations when clustered cases or outbreaks occur. Prevention measures may then be implemented (interruption of blood collection, quarantined donations, etc.). These measures can have an important impact, particularly by limiting the supply of blood products to health care facilities. It is therefore important for these measures to be adapted to the risk of transmission through blood transfusion. Quantitative risk estimates of blood donation contamination can therefore contribute to guiding those measures. In this context, in early 2005, the French Public Health Institute (InVS) started a project with the aim of obtaining a priori quantitative risk estimates of contamination of a blood donation by infectious agents for various scenarios in terms of incidence and time-space distribution. The objective of this article is to update the last estimates of residual risks of the major transfusion-transmitted viral infections (HIV, HTLV, HCV and HBV) and to present the work realized by the working group << Quantitative estimate of the risk of blood donation contamination by infectious agents>>.
Insights
Estimating transfusion-transmitted infections risk is crucial for blood safety. This study quantifies residual risks for major viral infections like HIV, HTLV, HCV, and HBV, aiding public health strategies.
Area of Science:
- Public Health
- Infectious Diseases
- Blood Transfusion Safety
Background:
- Asymptomatic infectious agents in blood pose a transfusion transmission risk.
- While HIV, HTLV, HCV, and HBV risks are controlled, others remain unquantified.
- Outbreaks can temporarily increase transfusion-transmitted infection risks.
Purpose of the Study:
- To update residual risk estimates for major transfusion-transmitted viral infections (HIV, HTLV, HCV, HBV).
- To present work on quantifying contamination risks for blood donations.
- To provide data for adapting prevention measures to transfusion risks.
Main Methods:
- Utilizing quantitative risk estimation models.
- Analyzing incidence and spatio-temporal distribution of infectious agents.
- Updating previous risk assessments for key viral pathogens.
Main Results:
- Provides updated quantitative estimates of residual transfusion risks.
- Documents the methodology for risk assessment of blood donation contamination.
- Highlights the importance of risk-based prevention strategies.
Conclusions:
- Accurate risk quantification is essential for effective blood safety policies.
- Updated estimates improve the management of transfusion-transmitted infection risks.
- This work supports evidence-based decision-making in blood product safety.
Related Concept Videos
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
